Also trades as: 1858.HK (HKSE) · $vol 1M
688236.SS SHH
Beijing Chunlizhengda Medical Instruments Co., Ltd.
1W: +0.6%
1M: +2.1%
3M: -6.2%
YTD: -38.0%
1Y: -36.9%
3Y: -38.4%
¥14.23 ($2.12)
+0.12 (+0.85%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$1.0B
+29.5% ▲
5Y CAGR: +2.2%
Gross Profit
$1.0B
+102.1% ▲
5Y CAGR: +8.9%
Operating Income
$302M
+130.8% ▲
5Y CAGR: -1.8%
Net Income
$272M
+117.7% ▲
5Y CAGR: -0.8%
EPS (Diluted)
$0.71
+115.2% ▲
5Y CAGR: -2.8%
EBITDA
$338M
+99.7% ▲
5Y CAGR: +0.2%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.2B | $806M | $1.0B |
| YoY Growth | +18.2% | +8.4% | +0.6% | -33.3% | +29.5% |
| Cost of Revenue | $264M | $302M | $353M | $289M | $0 |
| Gross Profit | $844M | $900M | $855M | $516M | $1.0B |
| Gross Margin | 76.2% | 74.9% | 70.8% | 64.1% | 100.0% |
| R&D Expenses | $105M | $162M | $157M | $133M | $0 |
| SG&A Expenses | $373M | $430M | $428M | $286M | $0 |
| Operating Expenses | $476M | $571M | $549M | $386M | $742M |
| Operating Income | $368M | $329M | $306M | $131M | $302M |
| Operating Margin | 33.2% | 27.4% | 25.3% | 16.2% | 28.9% |
| Interest Expense | $257K | $250K | $365K | $1M | $0 |
| Income Before Tax | $367M | $337M | $306M | $132M | $301M |
| Tax Expense | $45M | $29M | $28M | $7M | $29M |
| Net Income | $322M | $308M | $278M | $125M | $272M |
| Net Margin | 29.1% | 25.6% | 23.0% | 15.5% | 26.1% |
| EPS (Diluted) | $0.84 | $0.80 | $0.72 | $0.33 | $0.71 |
| EBITDA | $361M | $309M | $295M | $128M | $338M |
| Shares Outstanding | 384M | 384M | 386M | 383M | 383M |